PhaseBio Highlights Real-World Bleeding and Surgery Data Featured at The American College of Cardiology’s 70th Annual Scientific Session
Study leveraging the IBM® MarketScan® claims database examined bleeding events and rates of surgical procedures in patients initiating P2Y12 inhibitors, FXa inhibitors or dabigatran Analyses revealed that patients receiving P2Y12…
Read more


